Page last updated: 2024-10-30

lansoprazole and Hepatitis E

lansoprazole has been researched along with Hepatitis E in 1 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Hepatitis E: Acute INFLAMMATION of the LIVER in humans; caused by HEPATITIS E VIRUS, a non-enveloped single-stranded RNA virus. Similar to HEPATITIS A, its incubation period is 15-60 days and is enterically transmitted, usually by fecal-oral transmission.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ning, H1
Yu, S1
Zhu, Y1
Dong, S1
Yu, R1
Shen, S1
Niu, Z1
Li, Z1

Other Studies

1 other study available for lansoprazole and Hepatitis E

ArticleYear
Genotype 3 hepatitis E has been widespread in pig farms of Shanghai suburbs.
    Veterinary microbiology, 2008, Jan-01, Volume: 126, Issue:1-3

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Agriculture; Animals; Animals, Domestic; China; Feces; Gene

2008